PSMC3 |
PSMC3, TBP1: 26S protease regulatory subunit 6A |
PSMA2 |
PSMA2, PSC3: Proteasome subunit alpha type-2 |
4.847 |
Evidence |
O
|
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
4.847 |
Evidence |
|
RB1 |
RB1: Retinoblastoma-associated protein |
CCND2 |
CCND2: G1/S-specific cyclin-D2 |
4.847 |
Evidence |
|
CCND2 |
CCND2: G1/S-specific cyclin-D2 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
4.847 |
Evidence |
O
|
PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
4.847 |
Evidence |
|
TP53 |
TP53, P53: Cellular tumor antigen p53 |
RPA1 |
RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit |
4.842 |
Evidence |
|
RALA |
RALA, RAL: Ras-related protein Ral-A precursor |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
4.817 |
Evidence |
|
IFNAR2 |
IPI00220690 |
JAK1 |
|
4.805 |
Evidence |
|
LMO2 |
LMO2, RBTN2, RBTNL1, RHOM2, TTG2: Rhombotin-2 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
4.805 |
Evidence |
|
CD8A |
CD8A, MAL: T-cell surface glycoprotein CD8 alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
4.805 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
NMI |
NMI: N-myc-interactor |
4.805 |
Evidence |
|
BTG1 |
BTG1: Protein BTG1 |
CNOT8 |
CNOT8, CALIF, POP2: CCR4-NOT transcription complex subunit 8 |
4.802 |
Evidence |
O
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
EP300 |
IPI00478752 |
4.772 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
4.772 |
Evidence |
|
VTN |
VTN: Vitronectin precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
4.722 |
Evidence |
O
|
ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
4.722 |
Evidence |
|
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
4.722 |
Evidence |
|
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
CPB1 |
CPB1, CPB, PCPB: Carboxypeptidase B precursor |
4.722 |
Evidence |
|
SPINK1 |
SPINK1, PSTI: Pancreatic secretory trypsin inhibitor precursor |
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
4.722 |
Evidence |
|
MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
4.722 |
Evidence |
|
MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
RBBP7 |
RBBP7, RBAP46: Histone-binding protein RBBP7 |
4.715 |
Evidence |
|
BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
VDAC1 |
VDAC1, VDAC: Voltage-dependent anion-selective channel protein 1 |
4.685 |
Evidence |
|
GRB10 |
IPI00012752 |
DOK1 |
DOK1: Docking protein 1 |
4.685 |
Evidence |
|
SNAP23 |
SNAP23: Synaptosomal-associated protein 23 |
CFTR |
CFTR: Cystic fibrosis transmembrane conductance regulator ATP-binding cassette s |
4.682 |
Evidence |
|
EPOR |
EPOR: Erythropoietin receptor precursor |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
4.675 |
Evidence |
|